MedPath

Etodolac

ETODOLAC TABLETS, USP 400 mg and 500 mg Rx only

Approved
Approval ID

556a7d5f-2c3c-4efb-ac0c-fca140791602

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2025

Manufacturers
FDA

Preferred Pharmaceuticals Inc.

DUNS: 791119022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Etodolac

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68788-8846
Application NumberANDA076004
Product Classification
M
Marketing Category
C73584
G
Generic Name
Etodolac
Product Specifications
Route of AdministrationORAL
Effective DateMarch 24, 2025
FDA Product Classification

INGREDIENTS (8)

HYPROMELLOSE 2208 (100 MPA.S)Inactive
Code: B1QE5P712K
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
METHYLCELLULOSE (100 MPA.S)Inactive
Code: 4GFU244C4J
Classification: IACT
ETODOLACActive
Quantity: 400 mg in 1 1
Code: 2M36281008
Classification: ACTIB
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
POLYETHYLENE GLYCOL 1600Inactive
Code: 1212Z7S33A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Etodolac - FDA Drug Approval Details